Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

FHS
June 12, 2024
2:51 am

Short-term adverse effects of COVID-19 mRNA vaccinations are linked to higher and longer-lasting neutralizing antibody responses, indicating robust immune efficacy.

UVA Med School Faces Toxic Work Environment Allegations

Members of the University of Virginia (UVA) faculty senate have reportedly shown support for a group of medical school colleagues who have raised concerns about

September 27, 2024

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s Denecimig?

Denecimig is a monoclonal antibody commercialized by Novo Nordisk, with a leading Phase III program in Hemophilia A (Factor VIII Deficiency).

March 14, 2024

Discovery of antibiotic lolamicin that targets deadly bacteria without harming gut microbiome

Researchers discovered lolamicin, a selective Gram-negative antibiotic, effective against multidrug-resistant pathogens while sparing the gut microbiome.

June 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.